NASDAQ : ETON

Eton Pharmaceuticals, Inc. — Financial statements

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 53.67 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.53B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Eton Pharmaceuticals, Inc. (ETON) reported revenue of 105.59M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue105.59M79.95M39.01M31.64M21.25M21.83M
Cost of Revenue40.75M32.12M15.60M10.58M6.93M2.83M
Gross Profit64.85M47.83M23.41M21.06M14.32M19.00M
Selling, General & Admin38.45M35.24M22.34M18.93M18.58M14.27M
Research & Development5.76M7.76M3.25M3.32M4.00M6.23M
Operating Expenses44.21M43.00M25.59M22.25M22.58M20.50M
Operating Income20.64M4.83M-2.18M-1.19M-8.26M-1.50M
Interest Expense-4.57M-4.78M-2.00M-1.06M-955.00K-1.04M
Interest & Investment Income1.01M1.07M794.00K1.56M194.00K36.00K
EBT Excluding Unusual Items17.08M1.12M-3.39M-689.00K-9.02M-2.50M
Merger & Restructuring Charges-4.33M-5.67M-415.00K
Gain (Loss) on Sale of Assets181.00K
Other Unusual Items365.00K
Pretax Income12.75M-4.56M-3.81M-689.00K-9.02M-1.96M
Income Tax Expense63.00K43.00K15.00K247.00K
Net Income12.69M-4.60M-3.82M-936.00K-9.02M-1.96M
Net Income to Common12.69M-4.60M-3.82M-936.00K-9.02M-1.96M
Shares Outstanding (Basic)27.19M26.91M25.89M25.64M25.15M25.21M
Shares Outstanding (Diluted)29.61M26.91M25.89M25.64M25.15M25.21M
EPS (Basic)0.47-0.17-0.15-0.04-0.36-0.08
EPS (Diluted)0.43-0.17-0.15-0.04-0.36-0.08
Free Cash Flow14.73M10.19M943.00K6.82M4.78M-4.73M
Free Cash Flow Per Share0.500.380.040.270.19-0.19
Gross Margin61.41%59.83%60.01%66.56%67.38%87.05%
Operating Margin19.54%6.04%-5.59%-3.77%-38.87%-6.85%
Profit Margin12.02%-5.75%-9.80%-2.96%-42.45%-8.96%
Free Cash Flow Margin13.95%12.75%2.42%21.54%22.51%-21.66%
EBITDA25.18M8.88M-1.04M-291.00K-6.49M-1.12M
EBITDA Margin23.84%11.10%-2.66%-0.92%-30.52%-5.13%
D&A For EBITDA4.54M4.04M1.15M901.00K1.77M374.00K
EBIT20.64M4.83M-2.18M-1.19M-8.26M-1.50M
EBIT Margin19.54%6.04%-5.59%-3.77%-38.87%-6.85%
Revenue as Reported105.59M79.95M39.01M31.64M21.25M21.83M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents26.84M25.94M14.94M21.39M16.30M14.41M
Cash & Short-Term Investments26.84M25.94M14.94M21.39M16.30M14.41M
Receivables24.89M11.76M5.36M3.41M1.85M5.47M
Inventory10.14M15.42M15.23M911.00K557.00K550.00K
Prepaid Expenses6.72M7.46M5.49M1.13M1.29M3.18M
Total Current Assets68.60M60.58M41.02M26.84M20.00M23.60M
Property, Plant & Equipment1.47M636.00K209.00K150.00K260.00K219.00K
Other Intangible Assets45.68M30.88M34.88M4.74M4.75M3.62M
Other Long-Term Assets64.00K19.00K12.00K12.00K12.00K21.00K
Total Assets115.81M92.11M76.12M31.74M25.03M27.46M
Accounts Payable14.40M10.98M4.17M1.85M1.77M1.77M
Accrued Expenses18.95M15.94M15.70M8.96M3.66M1.37M
Current Portion of Long-Term Debt8.82M8.79M5.38M1.03M1.42M
Current Portion of Leases239.00K65.00K76.00K53.00K
Current Unearned Revenue330.00K457.00K
Other Current Liabilities2.38M2.26M
Total Current Liabilities45.12M38.49M19.95M16.24M6.46M4.56M
Long-Term Debt19.08M21.77M29.81M5.38M5.26M
Long-Term Leases1.08M460.00K107.00K22.00K107.00K15.00K
Long-Term Unearned Revenue1.62M1.76M
Other Long-Term Liabilities2.32M3.48M1.83M
Total Liabilities69.22M65.96M51.70M16.26M11.95M9.84M
Common Stock28.00K27.00K27.00K26.00K25.00K25.00K
Additional Paid-In Capital145.92M138.62M132.29M119.52M116.19M111.72M
Retained Earnings-99.36M-112.49M-107.89M-104.07M-103.13M-94.11M
Total Common Equity46.59M26.15M24.43M15.48M13.08M17.63M
Shareholders' Equity46.59M26.15M24.43M15.48M13.08M17.63M
Total Liabilities & Equity115.81M92.11M76.12M31.74M25.03M27.46M
Total Debt29.23M31.08M29.99M5.46M6.52M6.70M
Net Cash (Debt)-2.38M-5.14M-15.06M15.93M9.78M7.71M
Net Cash Per Share-0.08-0.19-0.580.620.390.31
Filing Date Shares Outstanding28.58M27.28M26.82M25.69M25.46M24.63M
Total Common Shares Outstanding28.29M27.05M26.71M25.69M25.35M24.63M
Working Capital23.48M22.09M21.07M10.60M13.54M19.05M
Book Value Per Share1.650.970.910.600.520.72
Tangible Book Value907.00K-4.72M-10.45M10.74M8.32M14.01M
Tangible Book Value Per Share0.03-0.17-0.390.420.330.57
Machinery237.00K517.00K377.00K350.00K341.00K395.00K
Construction In Progress12.00K
Leasehold Improvements229.00K295.00K103.00K103.00K71.00K71.00K

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income12.69M-4.60M-3.82M-936.00K-9.02M-1.96M
Depreciation & Amortization4.54M4.04M1.15M901.00K1.77M462.00K
Other Amortization632.00K696.00K1.11M117.00K127.00K148.00K
Loss (Gain) From Sale of Assets-181.00K
Stock-Based Compensation5.20M5.51M3.17M3.14M4.22M3.38M
Other Operating Activities4.87M5.73M599.00K82.00K62.00K-365.00K
Change in Accounts Receivable-10.43M-6.40M-3.12M-1.56M3.62M-5.42M
Change in Inventory9.87M-5.88M-1.84M-369.00K-7.00K692.00K
Change in Accounts Payable2.27M6.81M2.32M53.00K-8.00K-570.00K
Change in Other Net Operating Assets-14.50M4.61M1.41M5.39M4.06M-910.00K
Operating Cash Flow15.13M10.52M969.00K6.82M4.82M-4.72M
Capital Expenditures-403.00K-333.00K-26.00K-38.00K-9.00K
Sale of Property, Plant & Equipment700.00K
Cash Acquisitions-30.00M
Sale (Purchase) of Intangibles-15.00M-9.99M-775.00K-2.75M-3.25M
Investing Cash Flow-15.40M-333.00K-40.01M-775.00K-2.79M-2.56M
Long-Term Debt Issued25.31M
Long-Term Debt Repaid-1.16M-1.16M-385.00K-150.00K
Net Debt Issued (Repaid)-3.00M24.15M-1.16M-385.00K-150.00K
Issuance of Common Stock4.73M815.00K8.44M378.00K251.00K541.00K
Repurchase of Common Stock-180.00K
Financing Cash Flow1.73M815.00K32.59M-957.00K-134.00K391.00K
Net Cash Flow1.47M11.01M-6.45M5.08M1.90M-6.89M
Free Cash Flow14.73M10.19M943.00K6.82M4.78M-4.73M
Free Cash Flow Margin13.95%12.75%2.42%21.54%22.51%-21.66%
Free Cash Flow Per Share0.500.380.040.270.19-0.19
Levered Free Cash Flow6.58M11.16M-18.78M5.60M5.36M-7.02M
Unlevered Free Cash Flow8.80M13.45M-18.64M6.15M5.83M-6.52M
Cash Interest Paid4.17M3.33M665.00K842.00K730.00K815.00K
Cash Income Tax Paid114.00K118.00K82.00K247.00K
Change in Working Capital-12.80M-859.00K-1.23M3.51M7.66M-6.21M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization1.49B453.48M354.78M112.38M71.34M105.56M
Enterprise Value1.49B447.24M338.84M96.14M64.38M89.61M
Last Close Price52.1816.9113.324.382.824.29
Forward PE35.4430.5657.9179.6432.859.98
PS Ratio14.125.679.093.553.364.83
PB Ratio31.6917.3414.527.265.465.99
P/TBV Ratio1,644.4010.478.577.54
P/FCF Ratio101.2444.50376.2216.4914.91
P/OCF Ratio98.5443.09366.1216.4914.80
EV/Sales Ratio14.155.598.693.043.034.11
EV/EBITDA Ratio59.3350.39
EV/EBIT Ratio72.3992.58
EV/FCF Ratio101.4043.89359.3214.1113.46
Debt / Equity Ratio0.631.191.230.350.500.38
Debt / EBITDA Ratio1.153.47
Debt / FCF Ratio1.983.0531.810.801.36
Net Debt / Equity Ratio0.050.200.62-1.03-0.75-0.44
Net Debt / EBITDA Ratio0.100.58-14.5454.751.516.88
Net Debt / FCF Ratio0.160.5015.97-2.34-2.041.63
Asset Turnover0.970.950.721.110.810.81
Inventory Turnover2.402.101.9314.4212.533.15
Quick Ratio1.150.981.021.532.814.36
Current Ratio1.521.572.061.653.105.18
Return on Equity (ROE)35.97%-18.19%-19.16%-6.56%-58.75%-11.74%
Return on Assets (ROA)11.86%3.59%-2.53%-2.62%-19.67%-3.47%
Return on Capital Employed (ROCE)29.20%9.00%-3.90%-7.70%-44.50%-6.50%
Earnings Yield0.82%-1.01%-1.08%-0.83%-12.65%-1.85%
FCF Yield0.99%2.25%0.27%6.06%6.71%-4.48%
Buyback Yield / Dilution-11.94%-3.91%-0.97%-1.99%0.24%-19.98%